Your session is about to expire
← Back to Search
Other
MyTAP oral appliance plus mouth shield for Atrial Fibrillation
N/A
Waitlist Available
Led By Emet Schneiderman, PhD
Research Sponsored by Texas A&M University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
Study Summary
This study is evaluating whether a mouthguard may help reduce the number of atrial fibrillation events for individuals with atrial fibrillation.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
AF incidence
Periodontal conditions
Secondary outcome measures
Apnea hypopnea index after 1 month (T2) compared with T0-1
Epworth Sleepiness Scale (ESS); Score ≥10 is sleepy, ≥ 18 is very sleepy.
Heart rate variability analysis after 1 month compared with baseline (T0)
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: MyTAP oral appliance plus mouth shieldExperimental Treatment1 Intervention
MyTAP plus mouth shield
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MyTAP oral appliance plus mouth shield
2018
N/A
~50
Find a Location
Who is running the clinical trial?
Texas A&M UniversityLead Sponsor
140 Previous Clinical Trials
24,086 Total Patients Enrolled
Emet Schneiderman, PhDPrincipal InvestigatorTAMHSC
2 Previous Clinical Trials
151 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger